 Rigel Pharmaceuticals, Inc. NASDAQ:RIGL Q3 2022 Earnings Conference Call November 3, 2022 4:30 AM ET Company Participants Dolly Vance - Senior Advisor, Legal Corporate Affairs Raul Rodriguez - President and CEO Wolfgang Dummer - Executive Vice President and Chief Medical Officer Dave Santos - Executive Vice President and Chief Commercial Officer Dean Schorno - Executive Vice President and Chief Financial Officer Conference Call Participants Carly Kenselaar - Citi Kristen Kluska - Cantor Fitzgerald Eun Yang - Jefferies Dennis Resnick - BMO Capital Markets Operator Greetings, and welcome to the Rigel Pharmaceuticals Financial Conference Call for the Third Quarter 2022. At this time, all participants are in a listen-only-mode. 